1887

Innovation in Pharmaceutical Biotechnology

Comparing National Innovation Systems at the Sectoral Level

image of Innovation in Pharmaceutical Biotechnology

This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries - Belgium, Finland, France, Germany, Japan, the Netherlands, Norway and Spain. The report summarises the results of in-depth studies, providing a comparative analysis of participating countries' performance in science and innovation in biopharmaceuticals. It highlights specific characteristics of the national biopharmaceutical innovation systems in terms of their international openness and the specific role of demand-side factors in the innovation process. Major systemic failures affecting the functioning of the biopharmaceutical innovation systems are identified. Based on rich evidence, the report draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.

English

.

Policy Implications

The national reports prepared for this study identify some common sector-specific characteristics and systemic failures and policies for addressing these failures. By processes of mutual learning, governments can develop policy practices that are suited to the characteristics of their national biopharmaceutical innovation system.

English

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error